Lu Lin,Liang Wang,Xiao-Na Zhang,Xiao Li,Jian Wang,Zhu-Jun Shen,Wei Chen,Zheng-Yu Jin,Yi-Ning Wang
Abstract:To evaluate the diagnostic performance of 1.5-T non-contrast MR coronary angiography (MRCA) for detection of coronary artery disease (CAD) using whole-heart imaging combined with volume-targeted imaging.
What problem does this paper attempt to address?
The paper attempts to address the issue of improving the diagnostic accuracy of 1.5 Tesla non-contrast magnetic resonance coronary angiography (MRCA) in detecting coronary artery disease (CAD). Specifically, the study aims to evaluate the diagnostic performance of 1.5 Tesla non-contrast MRCA, combining whole-heart imaging and volume-targeted imaging, in detecting coronary artery stenosis.
### Background and Objectives
- **Background**: Coronary artery disease (CAD) is one of the major health issues in developed countries and one of the most common causes of death. Modern coronary CT angiography (CTA) has high accuracy in detecting obstructive coronary stenosis and is recommended as the initial non-invasive test for diagnosing CAD. However, magnetic resonance coronary angiography (MRCA), as a non-invasive alternative that does not require contrast agents or ionizing radiation, has not been widely used in clinical practice due to technical complexity, image instability, and lower diagnostic accuracy.
- **Objectives**: To design an optimal non-contrast MRCA scanning protocol combining whole-heart imaging and volume-targeted imaging, and to evaluate its diagnostic performance in detecting CAD, using conventional coronary angiography (CAG) as the reference standard.
### Methods
- **Study Population**: A total of 67 patients scheduled for non-emergency CAG were prospectively enrolled, with 45 patients included in the final analysis.
- **MRCA Acquisition**: Whole-heart MRCA and subsequent volume-targeted MRCA were performed under free-breathing conditions using a 1.5 Tesla clinical MRI system. No contrast agents, vasodilators, β-blockers, or abdominal belts were used in any of the patients.
- **Data Analysis**: Two observers independently evaluated the MRCA data using maximum intensity projection (MIP) and multiplanar reconstruction. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of MRCA were assessed using CAG results as the reference standard.
### Results
- **Diagnostic Performance**:
- **Whole-Heart MRCA**: Sensitivity per patient was 97%, specificity was 25%, and accuracy was 78%; sensitivity per vessel was 97%, specificity was 50%, and accuracy was 72%; sensitivity per segment was 87%, specificity was 74%, and accuracy was 77%.
- **Combined MRCA**: Sensitivity per patient was 97%, specificity was 83%, and accuracy was 93%; sensitivity per vessel was 95%, specificity was 85%, and accuracy was 90%; sensitivity per segment was 81%, specificity was 86%, and accuracy was 85%.
- **ROC Curve Analysis**: The area under the curve (AUC) for combined MRCA was significantly higher than for whole-heart MRCA, with 0.97 vs 0.85 per patient (p=0.0078), 0.96 vs 0.86 per vessel (p<0.0001), and 0.94 vs 0.82 per segment (p=0.046).
### Discussion
- **Main Findings**: The 1.5 Tesla non-contrast MRCA combining whole-heart imaging and volume-targeted imaging demonstrated high sensitivity and moderate specificity in detecting CAD, with a significant advantage in improving specificity. The diagnostic accuracy of combined imaging was significantly better than using whole-heart imaging alone.
- **Clinical Significance**: Combined MRCA is a practical and effective clinical strategy that can improve the diagnostic accuracy of non-contrast MRCA in detecting CAD, potentially promoting its further clinical application.
### Limitations
- **High CAD Prevalence**: The prevalence of CAD in the study group was 73%, with all patients having clinical indications for CAG. Further validation of the screening capability of combined MRCA is needed in patients with low to moderate CAD probability.
- **Lack of Emerging Acceleration Techniques**: Whole-heart MRCA did not implement emerging acceleration techniques such as compressed sensing and self-navigation, whose efficiency and impact on diagnostic performance need further evaluation.
- **Standardization of Volume-Targeted Imaging Location**: The location of volume-targeted imaging was standardized to the main trunks of the three major vessels, without considering abnormalities found in whole-heart imaging. Specific volume-targeted imaging may help assess coronary branches such as diagonal branches, posterior descending artery, and posterolateral branches.
By combining whole-heart imaging and volume-targeted imaging, this study significantly improved the diagnostic accuracy, particularly specificity, of 1.5 Tesla non-contrast MRCA in detecting CAD. This approach has the potential to become an effective clinical tool in the future.